Tim Bettington
Corporate Officer/Principal chez ELANCO ANIMAL HEALTH INCORPORATED
Fortune : 2 M $ au 31/03/2024
Profil
Tim Bettington is currently the Executive Vice President-Corporate Strategy at Elanco Animal Health, Inc. He previously worked as the Executive Vice President & President-US Operations at Zoetis, Inc. and as the Head-Commercial Operations at Boehringer Ingelheim Animal Health USA, Inc. from 2017 to 2019.
He has an undergraduate degree from the University of Western Sydney and a graduate degree from Macquarie Graduate School of Management Pty Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/04/2024 | 106 387 ( 0,02% ) | 2 M $ | 31/03/2024 |
Postes actifs de Tim Bettington
| Sociétés | Poste | Début |
|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Corporate Officer/Principal | 20/03/2023 |
Anciens postes connus de Tim Bettington
| Sociétés | Poste | Fin |
|---|---|---|
Boehringer Ingelheim Animal Health USA, Inc.
 Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Corporate Officer/Principal | 01/01/2019 |
| ZOETIS INC. | Corporate Officer/Principal | - |
Formation de Tim Bettington
| University of Western Sydney | Undergraduate Degree |
| Macquarie Graduate School of Management Pty Ltd. | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZOETIS INC. | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Boehringer Ingelheim Animal Health USA, Inc.
Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Health Technology |
